NAYA Biosciences, Inc.
NAYA · NASDAQ
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $619 | $3,009 | $2,759 | $36,098 |
| - Cash | $840 | $741 | $472 | $943 |
| + Debt | $8,838 | $9,895 | $5,335 | $5,377 |
| Enterprise Value | $8,616 | $12,163 | $7,623 | $40,532 |
| Revenue | $1,637 | $1,686 | $1,433 | $1,837 |
| % Growth | -2.9% | 17.6% | -22% | – |
| Gross Profit | $592 | $729 | $445 | $975 |
| % Margin | 36.2% | 43.2% | 31% | 53.1% |
| EBITDA | -$16,858 | -$3,214 | -$1,097 | -$1,645 |
| % Margin | -1,029.7% | -190.6% | -76.6% | -89.6% |
| Net Income | -$17,404 | -$3,623 | -$1,631 | -$2,245 |
| % Margin | -1,063% | -214.9% | -113.8% | -122.2% |
| EPS Diluted | -56.22 | -9.04 | -5.04 | -0.622 |
| % Growth | -521.9% | -79.4% | -710.3% | – |
| Operating Cash Flow | -$3,546 | -$617 | -$641 | -$1,456 |
| Capital Expenditures | -$15 | -$79 | $0 | -$55 |
| Free Cash Flow | -$3,560 | -$696 | -$641 | -$1,511 |